Literature DB >> 41541

Pharmacokinetics of the hypnotic benzodiazepine, temazepam.

P Bittencourt, A Richens, P A Toseland, J F Wicks, A N Latham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 41541      PMCID： PMC1429636          DOI： 10.1111/j.1365-2125.1979.tb00453.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Immediate and residual effects on human performance of the hydroxylated metabolites of diazepam [proceedings].

Authors:  C H Clarke; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

2.  Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules.

Authors:  L M Fuccella; G Bolcioni; V Tamassia; L Ferrario; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

3.  The effectiveness of temazepam as a hypnotic: an open, multi-centre assessment in 804 patients with sleep disorders.

Authors:  T V Harry; P A Johnson
Journal:  Curr Med Res Opin       Date:  1978       Impact factor: 2.580
  3 in total
  10 in total

1.  Pharmacokinetic aspects of rectal formulations of temazepam.

Authors:  L M Hanff; W J Rutten
Journal:  Pharm World Sci       Date:  1996-06

Review 2.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  The classification of benzodiazepine hypnotics.

Authors:  D M Pierce; R A Franklin
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

4.  Human orthostatic reflexes after taking temazepam at night.

Authors:  J M Patrick; M B Dikshit; I A Macdonald; P H Fentem
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

5.  The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.

Authors:  P R Bittencourt; P Wade; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

Review 6.  Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

7.  Pharmacodynamic correlates of modified absorption: studies with lormetazepam.

Authors:  D M Pierce; R A Franklin; T V Harry; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of the newer benzodiazepines.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; H R Ochs; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

9.  Pharmacokinetics of temazepam in geriatric patients.

Authors:  K Klem; G R Murray; K Laake
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  The effects of age and chronic liver disease on the elimination of temazepam.

Authors:  H Ghabrial; P V Desmond; K J Watson; A J Gijsbers; P J Harman; K J Breen; M L Mashford
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.